Ipamorelin vs Sermorelin
Updated November 4, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of Ipamorelin and Sermorelin (also searched as Sermorelin vs Ipamorelin) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
Ipamorelin centers on metabolic, while Sermorelin leans toward muscle. On indexed research, Sermorelin is ahead (Ipamorelin: 5 studies, Human evidence; Sermorelin: 18, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •Ipamorelin is strongest for metabolic; Sermorelin for muscle.
- •Evidence: Ipamorelin Human evidence (5 studies) vs Sermorelin Human evidence (18).
- •Both are research-use compounds — not FDA-approved.
Effect profiles, overlaid
At a glance
Ghrelin Agonist | Growth Hormone Release
GHRH Mimetic | Growth Hormone Deficiency
Ipamorelin vs Sermorelin: side-by-side
| Metric | Ipamorelin | Sermorelin |
|---|---|---|
| Class | Muscle | Muscle |
| Regulatory status | Research use only | Research use only |
| Evidence grade | Human evidence | Human evidence |
| Studies indexed | 5 | 18 |
| Research level | Preclinical | Moderate Research |
| Strongest effect | Metabolic & appetite | Muscle & body comp |
| Healing & recovery | 2.0 | 3.0▲ |
| Muscle & body comp | 3.0 | 4.0▲ |
| Metabolic & appetite | 3.0▲ | 3.0▲ |
| Neuro & mood | 2.0▲ | 2.0▲ |
| Sleep & circadian | 1.0▲ | 1.0▲ |
| Inflammation & immune | 1.0 | 2.0▲ |
| Skin & aesthetics | 2.0 | 3.0▲ |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | Ipamorelin | Sermorelin |
|---|---|---|
| Mechanism | Selective GH secretagogue / ghrelin-receptor agonist | GHRH (1–29) analog |
| Route | Subcutaneous injection | Subcutaneous injection |
| Half-life | ~2 h | — |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is Ipamorelin?
Ipamorelin is a synthetic peptide that acts as a selective agonist of the growth hormone secretagogue receptor, primarily stimulating growth hormone release. Its potential therapeutic applications are being explored in various contexts, including weight management and pain modulation.
Full Ipamorelin profile, mechanism & studies →What is Sermorelin?
Sermorelin is a synthetic peptide that acts as a growth hormone-releasing hormone (GHRH) analog, primarily stimulating the pituitary gland to enhance the secretion of endogenous growth hormone (GH). The mechanism of action involves binding to GHRH receptors on pituitary somatotrophs, leading to increased production and release of GH. This endogenous GH then exerts various physiological effects, including promoting growth, metabolism, and tissue repair.
Full Sermorelin profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | Sermorelin | 3.0/5 effect signal |
| Muscle | Sermorelin | 4.0/5 effect signal |
| Metabolic | Even | Both ~3.0/5 |
| Neuro | Even | Both ~2.0/5 |
| Sleep | Even | Both ~1.0/5 |
| Inflammation | Sermorelin | 2.0/5 effect signal |
| Skin | Sermorelin | 3.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack Ipamorelin and Sermorelin?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
Ipamorelin vs Sermorelin: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
Ipamorelin has 5 approved studies indexed (Human evidence), and Sermorelin has 18 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is Ipamorelin or Sermorelin better?
It depends on your goal. Ipamorelin is strongest for metabolic; Sermorelin for muscle. Sermorelin has more indexed studies (18). See the goal-by-goal breakdown above.
Is Ipamorelin or Sermorelin better for weight loss?
They score similarly on the metabolic/appetite axis in the community data.
Is Ipamorelin or Sermorelin better for muscle?
Sermorelin leads on the muscle & body-composition axis (4.0/5).
Which has more research, Ipamorelin or Sermorelin?
Ipamorelin has 5 approved studies indexed (Human evidence); Sermorelin has 18 (Human evidence). Higher counts mean more to read, not proven superiority.
Can you stack Ipamorelin and Sermorelin?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of Ipamorelin vs Sermorelin?
Ipamorelin: no community-reported effects logged yet. Sermorelin: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is Ipamorelin or Sermorelin FDA-approved?
Ipamorelin is a research-use compound and is not FDA-approved. Sermorelin is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is Sermorelin better than Ipamorelin?
For muscle, Sermorelin has the edge; for metabolic, Ipamorelin does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
Ipamorelin and Sermorelin are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed November 4, 2026.